Lymphocytic Leukemia Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Lymphocytic Leukemia stocks.

Lymphocytic Leukemia Stocks Recent News

Date Stock Title
Oct 1 EBS High Growth Tech Stocks To Watch This October 2024
Oct 1 TEVA Teva launches first U.S. generic against Novartis antidiarrheal Sandostatin LAR
Oct 1 TEVA Teva Announces Launch of the First and Only Generic Version of Sandostatin® LAR Depot (octreotide acetate for injectable suspension), in the U.S.
Oct 1 TEVA Why Are Analysts Bullish On Teva Pharmaceutical Industries Limited (TEVA) Right Now?
Sep 30 TEVA Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at 8 a.m. ET on November 6, 2024
Sep 30 TEVA $1000 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth This Much Today
Sep 30 TEVA Invesco EQV European Equity Fund Bolsters Position in Teva Pharmaceutical with a 1. ...
Sep 30 GMAB Is Genmab A/S (GMAB) One of the Best Revenue Growth Stocks to Buy According to Analysts?
Sep 28 TEVA Here are the Medicare Part D drugs expected to face 2025 price negotiations
Sep 27 TEVA Amazon to provide opioid overdose drug in workplace
Sep 27 EBS Amazon to provide opioid overdose drug in workplace
Sep 27 BIIB SAGE, BIIB End Collaboration for Neurology Candidate SAGE-324
Sep 26 GMAB Grant of Restricted Stock Units and Warrants to Employees in Genmab
Sep 26 EBS Emergent Bio gains after U.S. govt. order for smallpox therapy
Sep 26 BIIB Biogen Terminates Collaboration With Sage Therapeutics For Neurological Disorder Candidate
Sep 26 BIIB Biogen Terminates Collaboration With Sage Therapeutics For Neurological Disorder Candidate
Sep 26 EBS Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts
Sep 26 BIIB Biogen to end Sage deal for neuro candidate
Sep 26 BIIB Roche, Biogen kidney disease drug hits main goal in late-stage study
Sep 25 TEVA FTC weighs in on reverse-payment generic delay case involving Gilead, Teva
Lymphocytic Leukemia

Lymphocytic leukemia is a type of cancer that affects the white blood cells, or lymphocytes, in the body. It is a type of leukemia, which is a cancer of the blood and bone marrow. In lymphocytic leukemia, the body produces too many abnormal lymphocytes, which can crowd out healthy white blood cells, red blood cells, and platelets. This can lead to anemia, infections, and other serious health problems. Treatment for lymphocytic leukemia typically involves chemotherapy, radiation, and/or stem cell transplant.

Browse All Tags